Abstract
MiR-301a is as an oncogene involved in the regulation of gastric cancer (GC) progression, but the underlying mechanism is unclear. This study was to explore the lncRNA PCAT18/miR-301a/TP53INP1 axis in regulating the GC cell proliferation and metastasis. In the present study, GC tissues and cell lines were collected for the detection of PCAT18 expression. Herein, we found that PCAT18 is significantly decreases in human GC tissues and five GC cell lines. Overexpression of PCAT18 inhibits cell viability, invasion and migration of GC cells and tumour growth of GC xenograft tumours. PCAT18 negatively regulates the expression level of miR-301a. The interaction between PCAT18 and miR-301a is confirmed by RIP and RNA pull down. MiR-301a mimic increases cell viability and promotes cell migration and invasion and reverses the inhibitory action of PCAT18. TP53INP1 expression is negatively regulated by miR-301a and TP53INP1/miR-301a is involved in GC viability, migration and invasion. The promoting of PCAT18 on TP53INP1 expression is abolished by miR-301a overexpression. In conclusion, lncRNA PCAT18 acts as a tumour suppressor for GC and lncRNA PCAT18, miR-301a and TP53INP1 comprise a signal axis in regulating GC cell proliferation, migrat...Continue Reading
References
Mar 8, 2006·World Journal of Gastroenterology : WJG·Pei-Hong JiangNorio Sawabu
Jan 23, 2013·Journal of Gastroenterology·Ming WangBingya Liu
Mar 5, 2013·Genomics, Proteomics & Bioinformatics·Yamei NiuYun-Gui Yang
Jul 9, 2013·Journal of Surgical Oncology·Xiao-Dong XuZhong-Sheng Zhao
Jan 17, 2014·Nature·Yvonne TayPier Paolo Pandolfi
Feb 13, 2014·Oncotarget·Francesco CreaCheryl D Helgason
Mar 13, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Parisa KarimiFarin Kamangar
Jan 17, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yantian FangZongyou Chen
Sep 12, 2015·Journal of Medical Genetics·Xiaolong QiWang Ma
Mar 19, 2016·The Prostate·Robert K NamArun Seth
Aug 16, 2017·Molecular Cancer·Hui WangWenxin Qin
Aug 19, 2017·Nature Communications·Yong-Xi SongZhen-Ning Wang
Sep 10, 2017·EMBO Reports·Xiang-Song WuYing-Bin Liu
Oct 13, 2017·Nature·UNKNOWN GTEx ConsortiumStephen B Montgomery
Jan 15, 2018·Cancer Letters·Xiaojuan LiXingqiao Wen
Jan 19, 2018·Neuron·Yi-Lan WengGuo-Li Ming
Feb 2, 2018·Oncology Research·Wei LiXuan Yang
Mar 11, 2018·Oncology Research·Genglong ZhuZhidong Lin
Jun 9, 2018·Cancer Research·Xiaofeng WangZhengjun Qiu
Dec 7, 2018·International Journal of Molecular Sciences·Kobra ForoughiMehdi Manoochehri
Dec 21, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ZongYizhen Wang
May 28, 2019·Molecular Cancer·Xun LiXiaodong Ma
Jul 11, 2019·Journal of Physiology and Biochemistry·Jun ZhangYan Zhao
Aug 14, 2019·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xiao YueTingyi Xia
Aug 15, 2019·Oncogene·Jie ZhengPeng Gao